文章基本信息

标题：Anti-angiogenic and Anti-metastatic Effects of β-1,3-D-Glucan Purified from Hanabiratake, Sparassis crispa
本地全文：下载
作者：Kyosuke Yamamoto ; Takashi Kimura ; Akio Sugitachi 等
期刊名称：Biological and Pharmaceutical Bulletin
印刷版ISSN：0918-6158
电子版ISSN：1347-5215
出版年度：2009
卷号：32
期号：2
页码：259-263
DOI：10.1248/bpb.32.259
出版社：The Pharmaceutical Society of Japan
摘要：Sparassis crispa (SC), Hanabiratake in Japanese, is an edible mushroom with medicinal properties, that contains more than 40% β- D -glucan. It was concluded from results of the methylation study that β- D -glucan from SC (SBG) was composed of a backbone of β-(1→3)-linked D -glucopyranosyl residues, and had β- D -glucopyranosyl groups joined through O -6 and O -2 of D -glucose of the backbone. We purified SBG and investigated its anti-angiogenic functions and anti-metastatic effects on neoplasm using different animal models. The oral administration of the purified SBG suppressed B16-F10 cell-induced angiogenesis in the dorsal air sac assay using female ICR mice as well as vascular endothelial growth factor induced neovascularization in the Matrigel plug assay using female C57BL/6J mice. Furthermore, it suppressed the growth and numbers of the metastatic tumor foci in lung, along with the primary tumor growth in the spontaneous metastatic model using female C57BL/6J mice. From these results, it is apparent that the oral administration of SBG results in suppressive effect on tumor growth and metastasis in lung through the inhibition of tumor induced-angiogenesis. These effects are not a result of direct action on the endothelial cells because cell growth, migration and capillary-like tube formation were not affected in the human umbilical vein endothelial cells by SBG application. This is the first report showing that the oral administration of SBG is capable of suppressing angiogenesis and metastasis.
关键词：Sparassis crispa;β-(1→3)- D -glucan;anti-angiogenesis;anti-metastasis